Greystone Welcomes Denver’s Unique Apartment Group to National Sales Advisory Platform
Nov 02, 2016 13:23 pm UTC| Business
NEW YORK, Nov. 02, 2016 -- Greystone, one of the nation’s preeminent real estate lending, investment and advisory companies, announced that it has welcomed Denver-based Unique Apartment Group, a wholly owned subsidiary...
RedHill Biopharma Announces Withdrawal of Public Offering of its American Depositary Shares
Nov 02, 2016 13:20 pm UTC| Business
TEL-AVIV, Israel, Nov. 02, 2016 -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on the development and commercialization of late...
EyeGate Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Business Update
Nov 02, 2016 13:20 pm UTC| Business
WALTHAM, Mass., Nov. 02, 2016 -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) (“EyeGate” or the “Company”), a clinical-stage specialty pharmaceutical company that focuses on developing and commercializing products for...
UFP Technologies Announces Q3 Results
Nov 02, 2016 13:19 pm UTC| Business
NEWBURYPORT, Mass., Nov. 02, 2016 -- UFP Technologies, Inc.(Nasdaq:UFPT), an innovative designer and custom converter of foams, plastics, and natural fiber materials, today reported net income of $2.7 million or $0.37...
Nov 02, 2016 13:15 pm UTC| Business
COLORADO SPRINGS, Colo., Nov. 02, 2016 -- The Spectranetics Corporation (NASDAQ:SPNC) today announced that Dr. Sean Lyden presented the final 12-month results of the Stellarex Drug-coated Balloon (DCB) ILLUMENATE...
Adesto Technologies to Participate at the ROTH Technology Corporate Access Day on November 16
Nov 02, 2016 13:05 pm UTC| Business
SANTA CLARA, Calif., Nov. 02, 2016 -- Adesto Technologies Corporation (NASDAQ:IOTS), a leading provider of application-specific, ultra-low power non-volatile memory products, today announced Narbeh Derhacobian, chief...
Ocera Therapeutics Reports Third Quarter 2016 Financial Results and Company Update
Nov 02, 2016 13:05 pm UTC| Business
PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., Nov. 02, 2016 -- Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today reported...